Investors

“Portola is fortunate to have the confidence of high quality venture capitalists and institutional investors. Their unwavering commitment to our company and mission has been invaluable to our progress thus far.”

—Mardi Dier,
Portola CFO

Investors

Portola has raised $218 million in Series A, B and C rounds of financing with prominent investors of the biotechnology industry:
  • Abingworth Management
  • Adage Capital
  • Advance Technology Ventures
  • AllianceBernstein
  • Alta Partners
  • Apothecary Capital
  • Brookside Capital
  • China Investment and Development
  • DE Shaw
  • Frazier Healthcare
  • Goldman Sachs
  • IBT Management Corp.
  • Janus Capital
  • MPM Capital
  • PAC-LINK BioVentures
  • Prospect Ventures
  • Sutter Hill Ventures
  • T. Rowe Price
  • Teachers’ Private Capital